547 related articles for article (PubMed ID: 7723496)
1. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.
Brem H; Piantadosi S; Burger PC; Walker M; Selker R; Vick NA; Black K; Sisti M; Brem S; Mohr G
Lancet; 1995 Apr; 345(8956):1008-12. PubMed ID: 7723496
[TBL] [Abstract][Full Text] [Related]
2. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.
Brem H; Mahaley MS; Vick NA; Black KL; Schold SC; Burger PC; Friedman AH; Ciric IS; Eller TW; Cozzens JW
J Neurosurg; 1991 Mar; 74(3):441-6. PubMed ID: 1993909
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI
J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268
[TBL] [Abstract][Full Text] [Related]
4. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
[TBL] [Abstract][Full Text] [Related]
5. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study.
Valtonen S; Timonen U; Toivanen P; Kalimo H; Kivipelto L; Heiskanen O; Unsgaard G; Kuurne T
Neurosurgery; 1997 Jul; 41(1):44-8; discussion 48-9. PubMed ID: 9218294
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
[TBL] [Abstract][Full Text] [Related]
7. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.
Sampath P; Rhines LD; DiMeco F; Tyler BM; Park MC; Brem H
J Neurooncol; 2006 Oct; 80(1):9-17. PubMed ID: 16636748
[TBL] [Abstract][Full Text] [Related]
8. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
Sai K; Zhong MG; Wang J; Chen YS; Mou YG; Ke C; Zhang XH; Yang QY; Lin FH; Guo CC; Chen ZH; Zeng J; Lv YC; Li X; Gao WC; Chen ZP
J Neurol Sci; 2014 Aug; 343(1-2):60-5. PubMed ID: 24874252
[TBL] [Abstract][Full Text] [Related]
10. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Westphal M; Hilt DC; Bortey E; Delavault P; Olivares R; Warnke PC; Whittle IR; Jääskeläinen J; Ram Z
Neuro Oncol; 2003 Apr; 5(2):79-88. PubMed ID: 12672279
[TBL] [Abstract][Full Text] [Related]
11. Local treatment of malignant brain tumors using implantable chemotherapeutic polymers.
Gallia GL; Brem S; Brem H
J Natl Compr Canc Netw; 2005 Sep; 3(5):721-8. PubMed ID: 16194460
[TBL] [Abstract][Full Text] [Related]
12. Polymers to treat brain tumours.
Brem H
Biomaterials; 1990 Nov; 11(9):699-701. PubMed ID: 2090306
[TBL] [Abstract][Full Text] [Related]
13. Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors.
Emerich DF; Winn SR; Hu Y; Marsh J; Snodgrass P; LaFreniere D; Wiens T; Hasler BP; Bartus RT
Pharm Res; 2000 Jul; 17(7):767-75. PubMed ID: 10990193
[TBL] [Abstract][Full Text] [Related]
14. Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma.
Giese A; Kucinski T; Knopp U; Goldbrunner R; Hamel W; Mehdorn HM; Tonn JC; Hilt D; Westphal M
J Neurooncol; 2004 Feb; 66(3):351-60. PubMed ID: 15015668
[TBL] [Abstract][Full Text] [Related]
15. Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.
Olivi A; Ewend MG; Utsuki T; Tyler B; Domb AJ; Brat DJ; Brem H
Cancer Chemother Pharmacol; 1996; 39(1-2):90-6. PubMed ID: 8995504
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of recurrent malignant brain gliomas by surgical excision combined with biodegradable polymers of interstitial chemotherapy].
Qi ST; Qiu BH
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):58-61. PubMed ID: 15059361
[TBL] [Abstract][Full Text] [Related]
17. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapeutic wafers in treatment of malignant cerebral glioma. Assessment of a Cochrane review].
Kosteljanetz M; Poulsen HS
Ugeskr Laeger; 2010 Jan; 172(3):214-7. PubMed ID: 20089214
[TBL] [Abstract][Full Text] [Related]
19. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
[TBL] [Abstract][Full Text] [Related]
20. Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors.
Emerich DF; Winn SR; Snodgrass P; LaFreniere D; Agostino M; Wiens T; Xiong H; Bartus RT
Pharm Res; 2000 Jul; 17(7):776-81. PubMed ID: 10990194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]